251 related articles for article (PubMed ID: 16033948)
1. Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro.
Mathews JM; Etheridge AS; Valentine JL; Black SR; Coleman DP; Patel P; So J; Burka LT
Drug Metab Dispos; 2005 Oct; 33(10):1555-63. PubMed ID: 16033948
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human cytochrome P450 activities by kava extract and kavalactones.
Mathews JM; Etheridge AS; Black SR
Drug Metab Dispos; 2002 Nov; 30(11):1153-7. PubMed ID: 12386118
[TBL] [Abstract][Full Text] [Related]
3. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.
Weiss J; Sauer A; Frank A; Unger M
Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732
[TBL] [Abstract][Full Text] [Related]
4. Methysticin and 7,8-dihydromethysticin are two major kavalactones in kava extract to induce CYP1A1.
Li Y; Mei H; Wu Q; Zhang S; Fang JL; Shi L; Guo L
Toxicol Sci; 2011 Dec; 124(2):388-99. PubMed ID: 21908763
[TBL] [Abstract][Full Text] [Related]
5. Permeability studies of Kavalactones using a Caco-2 cell monolayer model.
Matthias A; Blanchfield JT; Penman KG; Bone KM; Toth I; Lehmann RP
J Clin Pharm Ther; 2007 Jun; 32(3):233-9. PubMed ID: 17489874
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells.
Whittaker P; Clarke JJ; San RH; Betz JM; Seifried HE; de Jager LS; Dunkel VC
Food Chem Toxicol; 2008 Jan; 46(1):168-74. PubMed ID: 17822821
[TBL] [Abstract][Full Text] [Related]
7. Densitometric analysis of kawain in kava-kava root extracts.
Janeczko Z; Krzek J; Pilewski N; Walusiak D
Acta Pol Pharm; 2001; 58(6):463-8. PubMed ID: 12197620
[TBL] [Abstract][Full Text] [Related]
8. Composition and biological activity of traditional and commercial kava extracts.
Côté CS; Kor C; Cohen J; Auclair K
Biochem Biophys Res Commun; 2004 Sep; 322(1):147-52. PubMed ID: 15313185
[TBL] [Abstract][Full Text] [Related]
9. Desmethoxyyangonin and dihydromethysticin are two major pharmacological kavalactones with marked activity on the induction of CYP3A23.
Ma Y; Sachdeva K; Liu J; Ford M; Yang D; Khan IA; Chichester CO; Yan B
Drug Metab Dispos; 2004 Nov; 32(11):1317-24. PubMed ID: 15282211
[TBL] [Abstract][Full Text] [Related]
10. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents.
Etheridge AS; Black SR; Patel PR; So J; Mathews JM
Planta Med; 2007 Jul; 73(8):731-41. PubMed ID: 17611934
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics of kavalactones after oral dosing of standardized kava extract in healthy volunteers.
Kanumuri SRR; Mamallapalli J; Nelson R; McCurdy CR; Mathews CA; Xing C; Sharma A
J Ethnopharmacol; 2022 Oct; 297():115514. PubMed ID: 35777607
[TBL] [Abstract][Full Text] [Related]
12. In vitro inhibition of carboxylesterase 1 by Kava (Piper methysticum) Kavalactones.
Melchert PW; Qian Y; Zhang Q; Klee BO; Xing C; Markowitz JS
Chem Biol Interact; 2022 Apr; 357():109883. PubMed ID: 35278473
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava).
Uebelhack R; Franke L; Schewe HJ
Pharmacopsychiatry; 1998 Sep; 31(5):187-92. PubMed ID: 9832350
[TBL] [Abstract][Full Text] [Related]
14. Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure.
Feltenstein MW; Lambdin LC; Ganzera M; Ranjith H; Dharmaratne W; Nanayakkara NP; Khan IA; Sufka KJ
Phytother Res; 2003 Mar; 17(3):210-6. PubMed ID: 12672148
[TBL] [Abstract][Full Text] [Related]
15. Kavalactones fail to inhibit alcohol dehydrogenase in vitro.
Anke J; Fu S; Ramzan I
Phytomedicine; 2006 Feb; 13(3):192-5. PubMed ID: 16428028
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).
Anke J; Ramzan I
J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747
[TBL] [Abstract][Full Text] [Related]
17. A stable isotope dilution tandem mass spectrometry method of major kavalactones and its applications.
Wang Y; Eans SO; Stacy HM; Narayanapillai SC; Sharma A; Fujioka N; Haddad L; McLaughlin J; Avery BA; Xing C
PLoS One; 2018; 13(5):e0197940. PubMed ID: 29795658
[TBL] [Abstract][Full Text] [Related]
18. Effects of Andrographis paniculata extract and Andrographolide on hepatic cytochrome P450 mRNA expression and monooxygenase activities after in vivo administration to rats and in vitro in rat and human hepatocyte cultures.
Pekthong D; Blanchard N; Abadie C; Bonet A; Heyd B; Mantion G; Berthelot A; Richert L; Martin H
Chem Biol Interact; 2009 May; 179(2-3):247-55. PubMed ID: 19041297
[TBL] [Abstract][Full Text] [Related]
19. Kava does not display metabolic toxicity in a homogeneous cellular assay.
Zou L; Harkey MR; Henderson GL; Dike LE
Planta Med; 2004 Apr; 70(4):289-92. PubMed ID: 15095141
[TBL] [Abstract][Full Text] [Related]
20. In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones.
Nerurkar PV; Dragull K; Tang CS
Toxicol Sci; 2004 May; 79(1):106-11. PubMed ID: 14737001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
